Pemetrexed 00480-4516-01
- Manufacturer
- Teva Pharmaceuticals, Inc.
- Dosage Form
- Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 1, 2022
- Listing Expires
- December 31, 2026
- Application
- NDA208419
Need to source Pemetrexed? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pemetrexed Monohydrate | 25 mg/mL |
Drug Class
Folate Analog Metabolic Inhibitor [EPC]Folic Acid Metabolism Inhibitors [MoA]
Selected Package
00480-4516-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4516-01) / 4 mL in 1 VIAL, SINGLE-DOSE